CSE bulletin 2019-0319
The subordinate voting shares of Vireo Health International Inc. have been approved for listing on the Canadian Securities Exchange.
Listing and disclosure documents will be available on the CSE website on the trading date.
Vireo is one of America's leading multistate cannabis companies. Vireo is a physician-led, science-focused organization, dedicated to providing patients with best-in-class
quality cannabis-based products and compassionate care. Vireo cultivates cannabis in environmentally friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third party dispensaries. Vireo
has a strong record of competing for and winning merit-based licensing processes and has been awarded licences in some of the most selective state-based markets, including Minnesota, New York, Pennsylvania, Maryland and Ohio.
Issuer: Vireo Health International
Security type: subordinate voting shares
Number of securities issued and outstanding: 21,014,514
Number of securities reserved for issuance (1): 88,762,024
CSE sector: life sciences
Cusip No.: 92767A107
Board lot: 100
Trading currency: Canadian dollar
Trading date: March 20, 2019
Other exchanges: not applicable
Fiscal year-end: Dec. 31
Transfer agent: Odyssey Trust Company
(1) There are 514,388 multiple voting shares and 65,411 supervoting shares issued and outstanding. Each supervoting share is convertible into one multiple voting share at the option of the holder or upon certain triggering events. Each multiple
voting share is convertible into 100 subordinate voting shares at the option of the holder or upon certain triggering events. This number also includes subordinate voting shares underlying existing and proposed convertible securities.
The exchange is accepting market-maker applications for VREO.
© 2019 Canjex Publishing Ltd. All rights reserved.